Aisling Capital Management LP - Q3 2023 holdings

$243 Million is the total value of Aisling Capital Management LP's 17 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 18.8% .

 Value Shares↓ Weighting
BBIO  BridgeBio Pharma Inc. (BBIO)$160,016,456
+53.3%
6,068,1250.0%65.94%
+29.0%
VRNA  Verona Pharma plc (VRNA)sponsored ads$18,180,238
-22.9%
1,115,3520.0%7.49%
-35.1%
SNDX  Syndax Pharmaceuticals, Inc. (SNDX)$14,883,000
-30.6%
1,025,0000.0%6.13%
-41.6%
BMEA  Biomea Fusion Inc (BMEA)$10,990,896
-37.3%
798,7570.0%4.53%
-47.3%
CMPS NewCompass Pathways Plc (CMPS)sponsored ads$7,137,000964,500
+100.0%
2.94%
GLUE  Monte Rosa Therapeutics Inc (GLUE)$7,052,465
-30.1%
1,472,3310.0%2.91%
-41.2%
RPHM  Reneo Pharmaceuticals Inc (RPHM)$6,743,031
+16.0%
886,0750.0%2.78%
-2.4%
NUVB  Nuvation Bio Inc. (NUVB)$3,404,952
-25.6%
2,541,0090.0%1.40%
-37.4%
ACRS  Aclaris Theraputics Inc (ACRS)$2,976,017
-33.9%
434,4550.0%1.23%
-44.4%
SPRB  Spruce Biosciences, Inc. (SPRB)$2,724,455
+5.1%
1,205,5110.0%1.12%
-11.6%
PSTX  Poseida Therapeutics Inc. (PSTX)$2,482,975
+35.2%
1,043,2670.0%1.02%
+13.8%
ELEV  Elevation Oncology Inc (ELEV)$1,878,411
-56.4%
2,834,9100.0%0.77%
-63.3%
AVRO  Avrobio, Inc. (AVRO)$1,555,060
+62.1%
1,009,7790.0%0.64%
+36.4%
 Marker Therapeutics, Inc. (MRKR)$1,426,857
+46.5%
314,2860.0%0.59%
+23.3%
NewAeglea Biotherapeutics Inc (AGLE)$828,65267,645
+100.0%
0.34%
VIRX  Viracta Therapeutics Inc (VIRX)$300,114
-26.2%
288,5710.0%0.12%
-37.7%
BCEL  Atreca Inc. (BCEL)$101,177
-73.4%
387,6530.0%0.04%
-77.4%
AGLE ExitAeglea Biotherapeutics Inc (AGLE)$0-1,691,151
-100.0%
-0.37%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Verona Pharma plc (VRNA)20Q3 202323.0%
AVROBIO, Inc. (AVRO)20Q3 202313.6%
Aclaris Theraputics Inc. (ACRS)20Q3 20236.6%
Aeglea Biotherapeutics Inc. (AGLE)19Q2 20237.5%
BridgeBio Pharma Inc. (BBIO)18Q3 202367.3%
Marker Therapeutics, Inc. (MRKR)18Q1 202311.7%
Atreca Inc. (BCEL)18Q3 20233.1%
Syndax Pharmaceuticals, Inc. (SNDX)15Q3 202317.2%
Zosano Pharma Corporation (ZSAN)15Q2 20225.8%
ObsEva SA (OBSV)14Q1 202218.5%

View Aisling Capital Management LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-07
13F-HR2023-11-13
13F-HR2023-08-11
13F-HR2023-05-09
13F-HR2023-02-09
13F-HR2022-11-03
13F-HR2022-08-10
13F-HR2022-05-10
13F-HR2022-02-18
13F-HR2021-11-12

View Aisling Capital Management LP's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (242681757.0 != 242681756.0)

Export Aisling Capital Management LP's holdings